monica padman glp 1 GLP-1 Update, Andy Roddick, Gold Wing Phase Monica Padman's Insights on Celebrity

GLP1 receptor agonist use was shown to be associated with a reduction in the risk for progression to cirrhosis in patients with MASLD and diabetes, and who started the medication early in the course of their disease, 13 leading the FDA to approve semaglutide for this condition in August 2025

If you have specific aesthetic goals or are curious about other treatments, be sure to discuss them with Melanie during your consultation

Clinical trials are underway to evaluate the safety and efficacy of D-allulose as a weight management tool

Expect headline-sensitive gap/drive behavior around filings, FDA milestones, and cross-trial comps

Nature 499 , 438443 (2013) Siu, F